๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA โ—† The UK-India CETA: A Deep Dive into Bilateral Pharmaceutical Value Chains, API Trade, and Medicine Price Trajectories โ—† Bilateral Breakthrough: How the Historic UK-India Free Trade Agreement Transforms Life Sciences and Key Trade Sectors โ—† Normalization or Correction? Irelandโ€™s Goods Exports Drop 29% in May as Pharma Surplus Narrows โ—† Pilot Photonics Secures โ‚ฌ10.4 Million EIC Accelerator Funding to Scale Deeptech Photonic Chips โ—† Intel Announces โ‚ฌ5 Billion ($5.7 Billion) AI-Driven Semiconductor Expansion at Leixlip, Kildare โ—† University of Galway to Lead New โ‚ฌ64.5m Research Ireland Rinn Medical Devices Centre โ—† Chanelle Pharma Renews Historic Partnership with Galway Races Summer Festival 2026 โ—† After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA โ—† The UK-India CETA: A Deep Dive into Bilateral Pharmaceutical Value Chains, API Trade, and Medicine Price Trajectories โ—† Bilateral Breakthrough: How the Historic UK-India Free Trade Agreement Transforms Life Sciences and Key Trade Sectors โ—† Normalization or Correction? Irelandโ€™s Goods Exports Drop 29% in May as Pharma Surplus Narrows โ—† Pilot Photonics Secures โ‚ฌ10.4 Million EIC Accelerator Funding to Scale Deeptech Photonic Chips โ—† Intel Announces โ‚ฌ5 Billion ($5.7 Billion) AI-Driven Semiconductor Expansion at Leixlip, Kildare โ—† University of Galway to Lead New โ‚ฌ64.5m Research Ireland Rinn Medical Devices Centre โ—† Chanelle Pharma Renews Historic Partnership with Galway Races Summer Festival 2026 โ—†
Updated 28 Jul 2026 ยท ClinicalTrials.gov

Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent Trials in Ireland

โ† All Irish trials

Every active and recruiting clinical study with an Irish site โ€” searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

2
Recruiting now
2
Active studies
Recruiting Phase 1/Phase 2
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
Princess Maxima Center for Pediatric Oncology ยท started 2025-10-01
๐Ÿ“ Dublin
NCT05745714 on ClinicalTrials.gov โ†—
Recruiting Phase 1/Phase 2
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
Princess Maxima Center for Pediatric Oncology ยท started 2023-11-14
๐Ÿ“ Dublin
NCT05658640 on ClinicalTrials.gov โ†—
No trials match your search.

Browse by location

Dublin ยท 85 Cork ยท 26 Galway ยท 24 Limerick ยท 14 Waterford ยท 13 Beaumont ยท 6 Sligo ยท 2 Tallaght ยท 2 Mullingar ยท 2 Elm Park ยท 2 Drogheda ยท 2 Wilton ยท 1

Browse by condition

Breast Cancer ยท 6 Ulcerative Colitis ยท 4 Prostate Cancer ยท 3 Crohn's Disease ยท 3 Coronary Arterial Disease (CAD) ยท 2 Idiopathic Pulmonary Fibrosis ยท 2 Multiple Myeloma ยท 2 Acute Lymphoblastic Leukemia, in โ€ฆ ยท 2 Lymphoblastic Lymphoma (Precursorโ€ฆ ยท 2 Lymphoblastic Lymphoma (Precursorโ€ฆ ยท 2 Lymphoblastic Lymphoma (Precursorโ€ฆ ยท 2 Ovarian Cancer ยท 2 Cancer ยท 2 Prostatic Neoplasms ยท 2
Cite this page

Priya Life Science (2026). Clinical Trials in Ireland Tracker. Available at: https://priyalifescience.com/clinical-trials-ireland/condition/lymphoblastic-lymphoma-precursor-b-lymphoblastic-lymphoma-leukaemia-recurrent (Accessed: 28 July 2026).

Embed this data โ†—

Source: ClinicalTrials.gov, U.S. National Library of Medicine โ€” studies listing at least one Irish site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see our EU Clinical Trials Tracker.